biomedical research without limits in action

Insane: By using the company structure of a decentralized autonomous organization (DAO) it seems to be possible to bypass any and all regulations. This has been demonstrated last Sunday when an investigational gene therapy, developed based on the results of a literature research by Andreas Stürmer, was used in an attempt to eliminate HSV2 from Aaron Traywick's body, CEO of Ascendance.